April 2026 – Myeloma News from the Journals Read more about April 2026 – Myeloma News from the JournalsAdd new comment
Living with Blood Cancer, Riding for a Cure: The Cyclists Taking on Iceland Read more about Living with Blood Cancer, Riding for a Cure: The Cyclists Taking on Iceland Add new comment
Blood Cancer Patients and Their Supporters Cycle Across Iceland to Raise Funds and Awareness for Multiple Myeloma and the International Myeloma Foundation’s Research Read more about Blood Cancer Patients and Their Supporters Cycle Across Iceland to Raise Funds and Awareness for Multiple Myeloma and the International Myeloma Foundation’s ResearchAdd new comment
Over 60 Million Showed They Are #MoreThanMyeloma During 2026 Myeloma Action Month Read more about Over 60 Million Showed They Are #MoreThanMyeloma During 2026 Myeloma Action Month Add new comment
Dr. Joseph Mikhael Steps into New Role as Medical Advisor for the International Myeloma Foundation Read more about Dr. Joseph Mikhael Steps into New Role as Medical Advisor for the International Myeloma Foundation Add new comment
CHMP-EMA Recommends Approval of Sarclisa (Isatuximab) as Subcutaneous Formulation Administered via On-Body Injector for Multiple Myeloma Read more about CHMP-EMA Recommends Approval of Sarclisa (Isatuximab) as Subcutaneous Formulation Administered via On-Body Injector for Multiple Myeloma Add new comment
CHMP-EMA Approves Darzalex (Daratumumab) as First Self-administered Oncology Injectable for Patients or Caregivers Read more about CHMP-EMA Approves Darzalex (Daratumumab) as First Self-administered Oncology Injectable for Patients or CaregiversAdd new comment
From OncoDaily: "Life Is More Than Myeloma" Read more about From OncoDaily: "Life Is More Than Myeloma" Add new comment
March 2026 – Myeloma News from the Journals Read more about March 2026 – Myeloma News from the JournalsAdd new comment
Phase 3 Success for Mezigdomide Signals New Path for Next-Generation CELMoD Therapies in Multiple Myeloma Read more about Phase 3 Success for Mezigdomide Signals New Path for Next-Generation CELMoD Therapies in Multiple MyelomaAdd new comment
